The boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies
Kortsalioudaki C, Taylor RM, Cheeseman P, Bansal S, Mieli-Vergani G, Dhawan A
10.1515/bc.2006.166 Biol
MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F et al
538,539 Compared with the control group, the ratio of kynurenine (KYN) to KYNA in HD increases significantly, which is related to the decrease in the production of KYNA in HD patients
(8) As both TB-500 and BPC-157 peptides appear to exhibit similar pharmacological potential, when blended together, the potential action of both may be maximized what would otherwise occur with one peptide, might occur at a better, faster rate when combined